We are proud to announce that our team member Monika Kvassheim will defend her thesis: “How Can Imaging and Modelling Contribute to Development of Alpha Therapies?” this Friday at the Radium Hospital.
We are please to announce that Caroline will give a talk on dosimetry in early phase clinical trials in an ESMIT webinar May 8th at 13:30-14:30 CEST. The faculty will be Marta Cremonesi and Caroline Stokke, with Anna Sarnelli as moderator. The lecture is open for all and will be available at the ESMIT platform also after the event. Dosimetry in Clinical Trials - The European School of Multimodality Imaging & Therapy (ESMIT)
Our group is proud to announce that we have been awarded the Division of Radiology and Nuclear Medicine (KRN) Best Article of the Year 2024/2025 for our outstanding work on the First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted ²¹²Pb Radioligand in Patients with Metastatic Castration-Resistant Prostate Cancer. The award was presented by division head Paulina Due-Tønnessen on Wednesday October 29th, followed by a presentation by senior author Caroline. This paper was a result of a fruitful collaboration between several groups at OUS, and the trial itself was sponsored by ARTBIO (PI Kjetil Berner from the Department of Oncology, OUS). Congratulations to our group members Eivor Hernes, Monika Kvassheim, Simen Rykkje Grønningsæter and Caroline Stokke, as well as the whole team on this well-deserved recognition!